Patent · US Active

Compounds

US9833452B2 · kind B2 · utility

5Cited by
9References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 11, 2016
Grant dateDec 5, 2017
Priority date
Expiry dateJul 11, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of formula (I):are described herein. Compounds of the disclosure are modulators of Kv3 channels and may be used in the prophylaxis or treatment of related disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.